NDC 0469-6501

LEXISCAN

Regadenoson

LEXISCAN is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Astellas Pharma Us, Inc.. The primary component is Regadenoson.

Product ID0469-6501_8fb5b92b-3654-43ff-98d3-3ac23c9a0b10
NDC0469-6501
Product TypeHuman Prescription Drug
Proprietary NameLEXISCAN
Generic NameRegadenoson
Dosage FormInjection, Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2008-04-10
Marketing CategoryNDA / NDA
Application NumberNDA022161
Labeler NameAstellas Pharma US, Inc.
Substance NameREGADENOSON
Active Ingredient Strength0 mg/mL
Pharm ClassesAdenosine Receptor Agonist [EPC],Adenosine Receptor Agonists [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 0469-6501-89

5 mL in 1 SYRINGE, PLASTIC (0469-6501-89)
Marketing Start Date2008-04-10
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0469-6501-05 [00469650105]

LEXISCAN INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA022161
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2008-04-10
Marketing End Date2011-10-20

NDC 0469-6501-89 [00469650189]

LEXISCAN INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA022161
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2008-04-10

Drug Details

Active Ingredients

IngredientStrength
REGADENOSON.08 mg/mL

OpenFDA Data

SPL SET ID:057289f4-2e18-4c1e-bed4-6c1858e2ef16
Manufacturer
UNII

Pharmacological Class

  • Adenosine Receptor Agonist [EPC]
  • Adenosine Receptor Agonists [MoA]
  • Adenosine Receptor Agonist [EPC]
  • Adenosine Receptor Agonists [MoA]

NDC Crossover Matching brand name "LEXISCAN" or generic name "Regadenoson"

NDCBrand NameGeneric Name
0469-6501LEXISCANregadenoson
55150-443regadenosonregadenoson
68083-175RegadenosonRegadenoson
71288-201RegadenosonRegadenoson

Trademark Results [LEXISCAN]

Mark Image

Registration | Serial
Company
Trademark
Application Date
LEXISCAN
LEXISCAN
78890527 3503116 Live/Registered
Astellas US LLC
2006-05-23

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.